Cubist Systematic Strategies LLC Makes New $2.72 Million Investment in Indivior PLC (NASDAQ:INDV)

Cubist Systematic Strategies LLC acquired a new stake in shares of Indivior PLC (NASDAQ:INDV - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 218,958 shares of the company's stock, valued at approximately $2,722,000. Cubist Systematic Strategies LLC owned about 0.16% of Indivior as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also made changes to their positions in the stock. Claret Asset Management Corp acquired a new position in Indivior in the fourth quarter worth about $9,304,000. CenterBook Partners LP raised its position in Indivior by 105.5% in the fourth quarter. CenterBook Partners LP now owns 1,147,841 shares of the company's stock worth $14,268,000 after purchasing an additional 589,158 shares in the last quarter. Marshall Wace LLP raised its position in Indivior by 659.7% in the fourth quarter. Marshall Wace LLP now owns 506,782 shares of the company's stock worth $6,299,000 after purchasing an additional 440,072 shares in the last quarter. Foursixthree Capital LP acquired a new position in Indivior in the fourth quarter worth about $4,639,000. Finally, SIH Partners LLLP bought a new stake in Indivior during the fourth quarter worth about $2,698,000. Institutional investors and hedge funds own 60.33% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Piper Sandler decreased their price objective on shares of Indivior from $16.00 to $13.00 and set an "overweight" rating on the stock in a research note on Thursday, March 6th. Rodman & Renshaw assumed coverage on shares of Indivior in a research note on Tuesday, January 28th. They set a "buy" rating and a $16.00 price objective on the stock. Finally, RODMAN&RENSHAW raised shares of Indivior to a "strong-buy" rating in a research note on Tuesday, January 28th.

Indivior Stock Up 1.9%

INDV stock traded up $0.21 during midday trading on Friday, reaching $11.28. The company's stock had a trading volume of 356,254 shares, compared to its average volume of 1,222,710. Indivior PLC has a 52 week low of $7.33 and a 52 week high of $18.59. The stock has a market cap of $1.55 billion, a PE ratio of -32.21 and a beta of 0.98. The business's 50-day simple moving average is $10.08 and its 200-day simple moving average is $10.60.

Indivior (NASDAQ:INDV - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.22 by $0.19. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. The firm had revenue of $266.00 million for the quarter, compared to analysts' expectations of $240.13 million. As a group, equities analysts forecast that Indivior PLC will post 1.22 earnings per share for the current fiscal year.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.